Jérôme Rossert

16.9k total citations · 4 hit papers
107 papers, 11.4k citations indexed

About

Jérôme Rossert is a scholar working on Nephrology, Hematology and Immunology. According to data from OpenAlex, Jérôme Rossert has authored 107 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Nephrology, 28 papers in Hematology and 26 papers in Immunology. Recurrent topics in Jérôme Rossert's work include Erythropoietin and Anemia Treatment (23 papers), Chronic Kidney Disease and Diabetes (18 papers) and Dialysis and Renal Disease Management (14 papers). Jérôme Rossert is often cited by papers focused on Erythropoietin and Anemia Treatment (23 papers), Chronic Kidney Disease and Diabetes (18 papers) and Dialysis and Renal Disease Management (14 papers). Jérôme Rossert collaborates with scholars based in France, United States and Germany. Jérôme Rossert's co-authors include Kai‐Uwe Eckardt, Andrew S. Levey, Josef Coresh, Adeera Levin, Norbert Lameire, Garabed Eknoyan, Dick de Zeeuw, Yusuke Tsukamoto, Thomas H. Hostetter and Marc Froissart and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jérôme Rossert

106 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

2005 2.8k citations Andrew S. Levey, Kai‐Uwe Eckardt et al. Kidney International profile →
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

2007 1.1k citations Andrew S. Levey, Josef Coresh et al. Kidney International profile →
Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD

2008 811 citations Lesley A. Stevens, Josef Coresh et al. American Journal of Kidney Diseases profile →
Predictive Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations for Estimating Renal Function

2005 603 citations Marc Froissart, Jérôme Rossert et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Jérôme Rossert

Since Specialization

Citations

This map shows the geographic impact of Jérôme Rossert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Rossert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Rossert more than expected).

Fields of papers citing papers by Jérôme Rossert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Rossert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Rossert. The network helps show where Jérôme Rossert may publish in the future.

Co-authorship network of co-authors of Jérôme Rossert

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Rossert. A scholar is included among the top collaborators of Jérôme Rossert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Rossert. Jérôme Rossert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review 2023 ·Journal of the American Society of Nephrology ·Dustin J. Little, Samvel B. Gasparyan, Patrick Schloemer, Niels Jongs, Meike Brinker, Martin Karpefors, (unknown), (unknown), Lars Frison, Richard Nkulikiyinka, Jérôme Rossert, Hiddo J.L. Heerspink	11
2	Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression 2023 ·Journal of the American Society of Nephrology ·Hiddo J.L. Heerspink, Niels Jongs, Patrick Schloemer, Dustin J. Little, Meike Brinker, (unknown), Martin Karpefors, David C. Wheeler, George L. Bakris, Vlado Perkovic, Richard Nkulikiyinka, Jérôme Rossert, Samvel B. Gasparyan	15
3	Perioperative THR-184 and AKI after Cardiac Surgery 2017 ·Journal of the American Society of Nephrology ·Jonathan Himmelfarb, Glenn M. Chertow, Peter A. McCullough, Thierry Mesana, Andrew Shaw, Thoralf M. Sundt, Craig Brown, (unknown), François Dagenais, Benoît de Varennes, Manuel L. Fontes, Jérôme Rossert, Jean‐Claude Tardif	32
4	Primary glomerulonephritis: an update on renal survival and determinants of progression 2008 ·QJM ·Olivier Moranne, Laurence Watier, Jérôme Rossert, Bénédicte Stengel, (unknown)	37
5	Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD breakdown → 2008 ·American Journal of Kidney Diseases ·Lesley A. Stevens, Josef Coresh, Christopher H. Schmid, Harold I. Feldman, Marc Froissart, John W. Kusek, Jérôme Rossert, Frederick Van Lente, R. Douglas Bruce, Yaping Zhang, Tom Greene, Andrew S. Levey	811
6	Effect of Early Correction of Anemia on the Progression of CKD 2006 ·American Journal of Kidney Diseases ·Jérôme Rossert, Adeera Levin, Simon D. Roger, Walter H. Hörl, Bruno Fouqueray, Cristiana Gassmann-Mayer, Dieter Frei, William M. McClellan	103
7	Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association 2006 ·Kidney International ·Carmen Lefaucheur, Bénédicte Stengel, Dominique Nochy, (unknown), Gary S. Hill, C. Jacquot, Jérôme Rossert, (unknown)	180
8	慢性腎臓疾患の定義と分類:腎臓疾患からの位置記載:全体的な転帰(KDIGO)の改善 2005 ·Kidney International ·Andrew S. Levey, K-U Eckardt, (unknown), (unknown), Joseph Coresh, Jérôme Rossert, (unknown), (unknown), Norbert Lameire, Garabed Eknoyan	6
9	Identification of two candidate collecting duct cell-specific cis-acting elements in the Hoxb-7 promoter region 2005 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Emmanuelle Plaisier, David Ribes, Pierre Ronco, Jérôme Rossert	3
10	Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) breakdown → 2005 ·Kidney International ·Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto, Adeera Levin, Josef Coresh, Jérôme Rossert, Dick de Zeeuw, Thomas H. Hostetter, Norbert Lameire, Garabed Eknoyan	2833
11	Anemia management and chronic renal failure progression 2005 ·Kidney International ·Jérôme Rossert, Marc Froissart, C. Jacquot	29
12	Pure Red-Cell Aplasia and Epoetin Therapy 2004 ·New England Journal of Medicine ·Charles L. Bennett, Stefano Luminari, Allen R. Nissenson, Martin S. Tallman, Stephen A. Klinge, (unknown), June M. McKoy, Benjamin Kim, E. A. Lyons, Steve Trifilio, Dennis W. Raisch, Andrew M. Evens, Timothy M. Kuzel, Glen T. Schumock, Steven M. Belknap, Francesco Locatelli, Jérôme Rossert, Nicole Casadevall	284
13	Predialysis survey on anemia management: Patient referral 2002 ·American Journal of Kidney Diseases ·Walter H. Hörl, Iain C. Macdougall, Jérôme Rossert, Piotr Rutkowski, Jean‐Pierre Wauters, Fernando Valderrábano	26
14	Upper extremity digital subtraction venography with gadoterate meglumine before fistula creation for hemodialysis 2001 ·Kidney International ·(unknown), M. Tassart, (unknown), Antoine Khalil, (unknown), Jérôme Rossert, Jean-Michel Bigot, F. Boudghène	19
15	Blocking Sp1 Transcription Factor Broadly Inhibits Extracellular Matrix Gene Expression In Vitro and In Vivo: Implications for the Treatment of Tissue Fibrosis 2001 ·Journal of Investigative Dermatology ·Franck Verrecchia, Alain Mauviel, Jérôme Rossert	104
16	Parathyroid hormone‐related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets 2001 ·British Journal of Pharmacology ·Thomas L. Clemens, Sarah Cormier, (unknown), Karlhans Endlich, Nathalie Fiaschi‐Taesch, Evelyne Fischer, Peter A. Friedman, Andrew C. Karaplis, Thierry Massfelder, Jérôme Rossert, Klaus‐Dieter Schlüter, Caroline Silve, Andrew F. Stewart, Karen K. Takane, Jean‐Jacques Helwig	146
17	MR-Guided PTA in Experimental Bilateral Rabbit Renal Artery Stenosis and MR Angiography Follow-Up Versus Histomorphometry 2000 ·CardioVascular and Interventional Radiology ·(unknown), Jérôme Rossert, Michel Wassef, Bernard Lévy, (unknown), F. Boudghène	13
18	Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients 1998 ·Medicine ·Ronald A. Asherson, Ricard Cervera, Jean‐Charles Piette, Josep Font, J. T. Lie, (unknown), (unknown), Francisco J. Muñoz, Roger A. Levy, François Boué, Jérôme Rossert, M Ingelmo	369
19	Autoreactive T cells in mercury-induced autoimmunity. Ability to induce the autoimmune disease. 1988 ·The Journal of Immunology ·Lucette Pelletier, Renaud Du Pasquier, Jérôme Rossert, M C Vial, Chantal Mandet, P Druet	108
20	Efficacy of intravenous spiramycin in the treatment of severe Legionnaires' disease 1988 ·Journal of Antimicrobial Chemotherapy ·Charles Mayaud, E Dournon, (unknown), Michel Denis, Jérôme Rossert, G Akoun	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact